| 1. |
國家衛生計生委辦公廳. 原發性肝癌診療規范 (2017 年版). 2017-06-02. http://www.moh.gov.cn/yzygj/s7659/201706/80abf02a86c048fcb130e5e298f7aeee.shtml.
|
| 2. |
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology, 2011, 53(3): 1020-1022.
|
| 3. |
European Association for The Study of The Liver; European Organisation for Research and Treatment of Cancer. EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol, 2012, 56(4): 908-943.
|
| 4. |
Tang ZY, Yu YQ, Lin ZY, et al. Small hepatocellular carcinoma: an analysis of 30 cases. Chin Med J (Engl), 1979, 92(7): 455-462.
|
| 5. |
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334(11): 693-699.
|
| 6. |
Mazzaferro V, Bhoori S, Sposito C, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl, 2011, 17: S44-S57.
|
| 7. |
四川大學華西醫院肝癌 MDT 團隊. 肝細胞癌切除術后復發轉移的防治: 華西醫院多學科專家共識. 中國普外基礎與臨床雜志, 2017, 24(8): 927-939.
|
| 8. |
中國抗癌協會肝癌專業委員會, 中華醫學會肝病學分會肝癌學組, 中國抗癌協會病理專業委員會, 等. 原發性肝癌規范化病理診斷指南 (2015 版). 臨床與實驗病理學雜志, 2015, 31(3): 241-246.
|